1. Geographically weighted linear combination test for gene-set analysis of a continuous spatial phenotype as applied to intratumor heterogeneity
   Payam Amini et al, 2023, Frontiers in Cell and Developmental Biology CrossRef
2. OMTX705, a Novel FAP-Targeting ADC Demonstrates Activity in Chemotherapy and Pembrolizumab-Resistant Solid Tumor Models
   Myriam Fabre et al, 2020, Clinical Cancer Research CrossRef
3. Cancer-associated fibroblasts: overview, progress, challenges, and directions
   Qinrong Ping et al, 2021, Cancer Gene Therapy CrossRef
4. Melanoma-associated fibroblasts impair CD8+ T cell function and modify expression of immune checkpoint regulators via increased arginase activity
   Barbara Érsek et al, 2021, Cellular and Molecular Life Sciences CrossRef
5. SAA1 is upregulated in gastric cancer-associated fibroblasts possibly by its enhancer activation
   Yoshimi Yasukawa et al, 2021, Carcinogenesis CrossRef
6. Gain-of-function p53 protein transferred via small extracellular vesicles promotes conversion of fibroblasts to a cancer-associated phenotype
   Shaolin Ma et al, 2021, Cell Reports CrossRef
7. iPSCs-Based Therapy for Trabecular Meshwork
   Wei Zhu et al, 2023, Human iPSC-derived Disease Models for Drug Discovery CrossRef
8. Fibroblast heterogeneity in prostate carcinogenesis
   Sathyavathi ChallaSivaKanaka et al, 2022, Cancer Letters CrossRef
9. PEDF regulates plasticity of a novel lipid–MTOC axis in prostate cancer-associated fibroblasts
   Francesca Nardi et al, 2018, Journal of Cell Science CrossRef
10. Cancer‐associated fibroblasts in nonsmall cell lung cancer: From molecular mechanisms to clinical implications
    Kit Yee Wong et al, 2022, International Journal of Cancer CrossRef
11. Cancer associated fibroblasts are distinguishable from peri‑tumor fibroblasts by biological characteristics in TSCC
    Pengfei Ba et al, 2019, Oncology Letters CrossRef
12. Epigenetics of Bladder Cancer: Where Biomarkers and Therapeutic Targets Meet
    Victor G. Martinez et al, 2019, Frontiers in Genetics CrossRef
13. Epigenetic Mechanisms Driving Tumor Supportive Microenvironment Differentiation and Function: A Role in Cancer Therapy?
    Marvin Sylvestre et al, 2020, Epigenomics CrossRef
14. Cancer–stroma interactions as a target for cancer treatment.
    I. V. Alekseenko et al, 2018, Biopolymers and Cell CrossRef
15. Epigenome Chaos: Stochastic and Deterministic DNA Methylation Events Drive Cancer Evolution
    Giusi Russo et al, 2021, Cancers CrossRef
16. Cancer-Associated Fibroblasts: Epigenetic Regulation and Therapeutic Intervention in Breast Cancer
    Yeuan Ting Lee et al, 2020, Cancers CrossRef
17. MEIS1 knockdown may promote differentiation of esophageal squamous carcinoma cell line KYSE‐30
    Reihaneh Alsadat Mahmoudian et al, 2019, Molecular Genetics & Genomic Medicine CrossRef
18. The Head and Neck Squamous Cell Carcinoma Microenvironment as a Potential Target for Cancer Therapy
    Jan Plzák et al, 2019, Cancers CrossRef
19. Epigenetic Reprogramming of Cancer-Associated Fibroblasts Deregulates Glucose Metabolism and Facilitates Progression of Breast Cancer
    Lisa M. Becker et al, 2020, Cell Reports CrossRef
20. Knockdown of sirtuin6 positively regulates acetylation of DNMT1 to inhibit NOTCH signaling pathway in non-small cell lung cancer cell lines
    Prabhu Subramani et al, 2023, Cellular Signalling CrossRef
21. DNA methylation signal has a major role in the response of human breast cancer cells to the microenvironment
    P Mathot et al, 2017, Oncogenesis CrossRef
22. Metabolic Reprogramming of Fibroblasts as Therapeutic Target in Rheumatoid Arthritis and Cancer: Deciphering Key Mechanisms Using Computational Systems Biology Approaches
    Sahar Aghakhani et al, 2020, Cancers CrossRef
23. Molecular mechanisms underlying the regulation of tumour suppressor genes in lung cancer
    Jia Yee Lee et al, 2024, Biomedicine & Pharmacotherapy CrossRef
24. Cancer-Associated Fibroblasts as a Common Orchestrator of Therapy Resistance in Lung and Pancreatic Cancer
    Andreas Domen et al, 2021, Cancers CrossRef
25. Cancer-Associated Fibroblasts: Understanding Their Heterogeneity
    Kévin Louault et al, 2020, Cancers CrossRef
26. Matrix Remodeling and Hyaluronan Production by Myofibroblasts and Cancer-Associated Fibroblasts in 3D Collagen Matrices
    Jiranuwat Sapudom et al, 2020, Gels CrossRef
27. Nanoparticles Targeted to Fibroblast Activation Protein Outperform PSMA for MRI Delineation of Primary Prostate Tumors
    Nicole Dmochowska et al, 2023, Small CrossRef
28. Upregulating MMP‑1 in carcinoma‑associated fibroblasts reduces the efficacy of Taxotere on breast cancer synergized by Collagen IV
    Qingyu Cui et al, 2018, Oncology Letters CrossRef
29. Small extracellular vesicle DNA-mediated horizontal gene transfer as a driving force for tumor evolution: Facts and riddles
    Gábor Valcz et al, 2022, Frontiers in Oncology CrossRef
30. Role of cancer-associated fibroblasts in tumor microenvironment
    Manzoor Ahmad Mir et al, 2022, Role of Tumor Microenvironment in Breast Cancer and Targeted Therapies CrossRef
31. T Cell–Mediated Antitumor Immunity Cooperatively Induced By TGFβR1 Antagonism and Gemcitabine Counteracts Reformation of the Stromal Barrier in Pancreatic Cancer
    Dandan Li et al, 2021, Molecular Cancer Therapeutics CrossRef
32. Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts
    Linda Ziani et al, 2018, Frontiers in Immunology CrossRef
33. Tumor-educated mesenchymal stem cells promote pro-metastatic phenotype
    Billy Samuel Hill et al, 2017, Oncotarget CrossRef
34. Natural Compounds Targeting Cancer-Associated Fibroblasts against Digestive System Tumor Progression: Therapeutic Insights
    Kuan-Jung Chiu et al, 2022, Biomedicines CrossRef
35. Cancer Stem Complex, Not a Cancer Stem Cell, Is the Driver of Cancer Evolution
    E. D. Sverdlov et al, 2019, Biochemistry (Moscow) CrossRef
36. NOTCH1 gene amplification promotes expansion of Cancer Associated Fibroblast populations in human skin
    Atul Katarkar et al, 2020, Nature Communications CrossRef
37. Notch Signaling in Breast Tumor Microenvironment as Mediator of Drug Resistance
    Adele Chimento et al, 2022, International Journal of Molecular Sciences CrossRef
38. CSL controls telomere maintenance and genome stability in human dermal fibroblasts
    Giulia Bottoni et al, 2019, Nature Communications CrossRef
39. Targeting the tumour stroma to improve cancer therapy
    Kenneth C. Valkenburg et al, 2018, Nature Reviews Clinical Oncology CrossRef
40. Long non-coding RNAs as pan-cancer master gene regulators of associated protein-coding genes: a systems biology approach
    Asanigari Saleembhasha et al, 2019, PeerJ CrossRef
41. Missed Druggable Cancer Hallmark: Cancer–Stroma Symbiotic Crosstalk as Paradigm and Hypothesis for Cancer Therapy
    Eugene Sverdlov, 2018, BioEssays CrossRef
42. Methylation-Based Therapies for Colorectal Cancer
    Klara Cervena et al, 2020, Cells CrossRef
43. Fibroblast heterogeneity in tumor micro-environment: Role in immunosuppression and new therapies
    Rana Mhaidly et al, 2020, Seminars in Immunology CrossRef
44. Stromal-induced mitochondrial re-education: Impact on epithelial-to-mesenchymal transition and cancer aggressiveness
    Marina Bacci et al, 2020, Seminars in Cell & Developmental Biology CrossRef
45. c-Met Signaling as a Therapeutic Target in Head and Neck Cancer
    Sara M. Centuori et al, 2022, The Cancer Journal CrossRef
46. Teaming Up for Trouble: Cancer Cells, Transforming Growth Factor-β1 Signaling and the Epigenetic Corruption of Stromal Naïve Fibroblasts
    Sergio Lamprecht et al, 2018, Cancers CrossRef
47. Geostatistical Modeling and Heterogeneity Analysis of Tumor Molecular Landscape
    Morteza Hajihosseini et al, 2022, Cancers CrossRef